Osteotec, a Newbury, U.K.-based manufacturer and distributor of specialized medical devices, has announced an exclusive agreement to distribute Cerapedics Inc.’s i-FACTOR bone graft portfolio in the U.K. and Ireland. This agreement expands Osteotec’s offerings, enabling healthcare professionals to access Cerapedics’ i-FACTOR Bone Graft Putty and i-FACTOR Bone Graft FLEX FR products for spine procedures. The…more
Terumo Blood and Cell Technologies (Terumo BCT) has announced funding support for a multi-center clinical trial aimed at reducing complications from acute chest syndrome (ACS) in adult patients with sickle cell disease (SCD). Researchers at Henri Mondor University Hospital in France will lead the trial, known as ARCAD, to evaluate the efficacy and safety of…more
Terumo Blood and Cell Technologies (Terumo BCT) has announced a strategic partnership with Terumo Medical Products (Hangzhou) Co. Ltd., investing in a production facility in Qiantang District, Hangzhou. This initiative aims to provide locally made medical products for the Chinese market, including devices used to collect and separate blood and cells. The launch ceremony, themed…more
Lakewood-based Terumo Blood and Cell Technologies (Terumo BCT) has announced the establishment of its new Global Therapy Innovations business unit. The unit aims to integrate disease expertise throughout the patient journey, from cell collections to therapy delivery, and is led by Veerle d’Haenens, general manager, Global Therapy Innovations. The initiative intends to enhance standards of…more
Terumo Blood and Cell Technologies (Terumo BCT) is scaling up its offerings in Latin America to promote the adoption of automated manufacturing for cell and gene therapy companies in Brazil, Colombia and Mexico. The company aims to enhance efficiency and cost-effectiveness in the manufacturing process for regional firms. Cell and gene therapies are rapidly advancing…more